EyePoint EYPT
NASDAQ EYPT
$0.36 +0.00 (+0.53%)
At close: Nov 9, 2026 · 4:00 PM EST

EyePoint (EYPT) EV to EBIT (2014 - 2015)

Updated

EyePoint's EV to EBIT came in at 12.83 for Q4 2015, up 15.5% from the prior quarter.

Analysis

EyePoint (EYPT) EV to EBIT (2014 - 2015) Analysis & Trends

Going back to Q1 2015, EyePoint's EV to EBIT data covers 4 quarters.

  • Business Quant data shows EYPT's EV to EBIT at 11.11 (Q3 2015), 8.16 (Q2 2015) and 10.47 (Q1 2015) in the three quarters before Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 EyePoint 31.41 Mn -881.72 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 12.83
Mar 31, 2015 11.11
Dec 31, 2014 8.16
Sep 30, 2014 10.47
API Access

EyePoint EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=EYPT&period=max&api_key=YOUR_API_KEY